Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer

International Journal of Gynecological Cancer

Volumn 26, Issue 6, 2016, Pages 1169-1175

  Onal, Cem ^a   Guler, Ozan C ^a   Yildirim, Berna A ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cervical cancer; Neutrophil to lymphocyte ratio; Platelet to lymphocyte ratio; Prognostic index; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; NEUTROPHIL LYMPHOCYTE RATIO; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER; BLOOD; CONFORMAL RADIOTHERAPY; LYMPHOCYTE; NEUTROPHIL; PATHOLOGY; PROGNOSIS; THROMBOCYTE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; BRACHYTHERAPY; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; HUMANS; LYMPHOCYTES; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84977564075     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000741     Document Type: Article

References (33)

1. Siegel R Naishadham D Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. Eifel PJ Winter K Morris M Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004; 22: 872-880.
3. Atahan IL Onal C Ozyar E Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007; 17: 833-842.
4. Rosa DD Medeiros LR Edelweiss MI Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev. 2012; 6: CD005342.
5. Schwarz JK Siegel BA Dehdashti F Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007; 298: 2289-2295.
6. Onal C Reyhan M Parlak C Prognostic value of pretreatment 18 F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Int J Gynecol Cancer. 2013; 23: 1104-1110.
7. Micco M Vargas HA Burger IA Combined pre-treatment MRI and 18 F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol. 2014; 83: 1169-1176.
8. Hanahan D Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674.
9. Coussens LM Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867.
10. Lee YY Choi CH Kim HJ Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res. 2012; 32: 1555-1561.
11. Walsh SR Cook EJ Goulder F Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005; 91: 181-184.
12. Sarraf KM Belcher E Raevsky E Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137: 425-428.
13. Zhang GM Zhu Y Ma XC Pretreatment neutrophil-to-lymphocyte ratio: a predictor of advanced prostate cancer and biochemical recurrence in patients receiving radical prostatectomy. Medicine (Baltimore). 2015; 94: e1473.
14. Templeton AJ McNamara MG Seruga B Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106: 1-11.
15. Hefler LA Concin N Hofstetter G Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008; 14: 710-714.
16. Gomez D Farid S Malik HZ Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008; 32: 1757-1762.
17. Sugiura T Uesaka K Kanemoto H Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol. 2013; 20: 4330-4337.
18. Pichler M Hutterer GC Stoeckigt C Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013; 108: 901-907.
19. Mizunuma M Yokoyama Y Futagami M The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Int J Clin Oncol. 2015; 20: 989-996.
20. Onal C Arslan G Topkan E Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009; 28: 95.
21. Onal C Reyhan M Guler OC Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2014; 41: 1336-1342.
22. Vakkila J Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004; 4: 641-648.
23. Mantovani A Allavena P Sica A Cancer-related inflammation. Nature. 2008; 454: 436-444.
24. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001; 411: 380-384.
25. Rashid F Waraich N Bhatti I A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol. 2010; 8: 1.
26. Alexandrakis MG Passam FH Moschandrea IA Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol. 2003; 26: 135-140.
27. Smyth SS McEver RP Weyrich AS Platelet functions beyond hemostasis. J Thromb Haemost. 2009; 7: 1759-1766.
28. Dashevsky O Varon D Brill A. Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer. 2009; 124: 1773-1777.
29. Jankova L Dent OF Chan C Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. BMC Cancer. 2013; 13: 442.
30. Choi CH Kang H Kim WY Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Int J Radiat Oncol Biol Phys. 2008; 71: 199-204.
31. Fernandes PC Jr Garcia CB Micheli DC Circulating neutrophils may play a role in the host response in cervical cancer. Int J Gynecol Cancer. 2007; 17: 1068-1074.
32. Wang D Wu M Feng FZ Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy. Chin Med J (Engl). 2013; 126: 1464-1468.
33. Lee Y Kim SH Han JY Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol. 2012; 138: 2009-2016.